95. Tirzepatide Once Weekly for the Treatment of Obesity

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/8e/2f/ca/8e2fcae1-17ae-b95e-b2d5-bb1b89a96281/mza_6105715200048338125.jpg/600x600bb.jpg

Healthspan

Michael Salzle

94 episodes

3 days ago

Become a Paid Subscriber: https://podcasters.spotify.com/pod/show/michael-salzle/subscribe Healthspan. The podcast that will add years to your life, and life to your years

Fitness

Health & Fitness

RSS

All content for Healthspan is the property of Michael Salzle and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Become a Paid Subscriber: https://podcasters.spotify.com/pod/show/michael-salzle/subscribe Healthspan. The podcast that will add years to your life, and life to your years

Fitness

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/5102232/5102232-1590559455956-ec4f01f2b0c47.jpg

95. Tirzepatide Once Weekly for the Treatment of Obesity

Healthspan

14 minutes 15 seconds

11 months ago

95. Tirzepatide Once Weekly for the Treatment of Obesity

SURMOUNT 1 Trial. The aim of this trial was to investigate the safety and efficacy of Tirzepatide, a novel GLP + GIP in people with obesity. We discuss the trial in this episode.